PTGER3 encodes a receptor for prostaglandin E2 that is targeted by misoprostol, an approved drug for gastric ulcers and reflux disease and which has shown efficacy in colon cancer xenograft models62. This evidence concerns the gene PTGER3 and colonic neoplasm.